Ironwood Pharmaceuticals (IRWD) Change in Acquisitions & Divestments (2016 - 2018)
Ironwood Pharmaceuticals (IRWD) has disclosed Change in Acquisitions & Divestments for 9 consecutive years, with $19.9 million as the latest value for Q4 2018.
- Quarterly Change in Acquisitions & Divestments fell 28.48% to $19.9 million in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $99.2 million through Dec 2018, down 71.41% year-over-year, with the annual reading at $99.2 million for FY2018, 71.41% down from the prior year.
- Change in Acquisitions & Divestments hit $19.9 million in Q4 2018 for Ironwood Pharmaceuticals, up from $16.8 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $212.0 million in Q3 2015 to a low of $13.9 million in Q2 2018.
- Historically, Change in Acquisitions & Divestments has averaged $65.0 million across 5 years, with a median of $48.6 million in 2018.
- Biggest five-year swings in Change in Acquisitions & Divestments: skyrocketed 699.65% in 2015 and later tumbled 89.8% in 2016.
- Year by year, Change in Acquisitions & Divestments stood at $52.5 million in 2014, then soared by 303.99% to $212.0 million in 2015, then plummeted by 84.23% to $33.4 million in 2016, then decreased by 16.99% to $27.8 million in 2017, then dropped by 28.48% to $19.9 million in 2018.
- Business Quant data shows Change in Acquisitions & Divestments for IRWD at $19.9 million in Q4 2018, $16.8 million in Q3 2018, and $13.9 million in Q2 2018.